Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maurice D. Laryea"'
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45110 (2012)
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patie
Externí odkaz:
https://doaj.org/article/e488ed6eedc74f2f86850021d402f2e8
Autor:
Frank ter Veld, Martina Mueller, Simone Kramer, Ulrike Haussmann, Diran Herebian, Ertan Mayatepek, Maurice D Laryea, Sonja Primassin, Ute Spiekerkoetter
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e6449 (2009)
BACKGROUND:Newborn screening for medium- and very long-chain acyl-CoA dehydrogenase (MCAD and VLCAD, respectively) deficiency, using acylcarnitine profiling with tandem mass spectrometry, has increased the number of patients with fatty acid oxidation
Externí odkaz:
https://doaj.org/article/31cddb109e244951bd50603a3581e4e3
Autor:
Sebastian Illes, Jessica Opatz, Maurice D. Laryea, Mario Siebler, Frauke Otto, Hans-Peter Hartung, Alfons Schnitzler, Marcel Dihné, Stephan Theiss
Publikováno v:
Annals of Neurology. 66:546-555
Neurological diseases frequently induce pathological changes of cerebrospinal fluid (CSF) that might secondarily influence brain activity, as the CSF–brain barrier is partially permeable. However, functional effects of CSF on neuronal network activ
Autor:
Maurice D. Laryea, Ute Spiekerkötter, Marc Lamshöft, Diran Herebian, Eva Thimm, Ertan Mayatepek
Publikováno v:
Journal of Chromatography B. 877:1453-1459
In this study, we describe a bioanalytical method for quantification of NTBC in plasma of patients with hereditary tyrosinemia type 1 (HT-1) using high-performance liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). After protein
Autor:
Guido Kagemann, Ronald Wolf, Markus Walz, Maurice D. Laryea, Helmut Sies, Victoria Kolb-Bachofen, Maximilian Schuier, Ertan Mayatepek, Christoph V. Suschek, Oliver Schnorr, Thomas Ruzicka
Publikováno v:
Free Radical Biology and Medicine. 38:1073-1079
Regulated uptake of extracellular l-arginine by cationic amino acid transporters (CATs) is required for inducible nitric oxide synthase and arginase activity. Both enzymes were recently recognized as important in the pathophysiology of psoriasis beca
Autor:
Sylvain Morneau, Véronique A. Pelletier, Jean-Michel Liet, U. Wendel, Brian H. Robinson, Maurice D. Laryea, Charles Morin, Jacques Lacroix, Grant A. Mitchell
Publikováno v:
The Journal of Pediatrics. 142:62-66
Objective To study the effectiveness of dimethylglycine (DMG) on oxygen consumption (VO2) in children with Saguenay-Lac-Saint-Jean cytochrome-c oxidase (SLSJ-COX) deficiency (OMIM 220111). Study design In a crossover randomized double-blind clinical
Publikováno v:
Clinical Chemistry. 44:1937-1941
A simple and convenient method using commercially available derivatization reagents is described for the measurement of betaine and N,N-dimethylglycine (DMG) in blood and urine. Precolumn derivatization of plasma or urine is performed directly in ace
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45110 (2012)
PLoS ONE
PLoS ONE
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patie
Publikováno v:
Journal of inherited metabolic disease. 33
Inborn errors of urea metabolism result in hyperammonemia. Treatment of urea cycle disorders can effectively lower plasma ammonium levels and results in survival in the majority of patients. Available medications for treating urea cycle disorders inc
Autor:
Diran Herebian, Frank ter Veld, Ertan Mayatepek, Ulrike Haussmann, Martina Mueller, Simone Kramer, Sonja Primassin, Ute Spiekerkoetter, Maurice D. Laryea
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e6449 (2009)
PLoS ONE
PLoS ONE
Background Newborn screening for medium- and very long-chain acyl-CoA dehydrogenase (MCAD and VLCAD, respectively) deficiency, using acylcarnitine profiling with tandem mass spectrometry, has increased the number of patients with fatty acid oxidation